You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 3, 2025

Drug Price Trends for GENTEAL TEARS SEVERE GEL DROPS


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for GENTEAL TEARS SEVERE GEL DROPS

Average Pharmacy Cost for GENTEAL TEARS SEVERE GEL DROPS

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
GENTEAL TEARS SEVERE GEL DROPS 00065-8067-01 1.16875 ML 2024-08-21
GENTEAL TEARS SEVERE GEL DROPS 00065-8067-01 1.13725 ML 2024-05-22
GENTEAL TEARS SEVERE GEL DROPS 00065-8067-01 1.13725 ML 2024-04-17
>Drug Name >NDC >Price/Unit ($) >Unit >Date

GENTEAL TEARS SEVERE GEL DROPS Market Analysis and Financial Projection

Market Analysis and Price Projections for GenTeal Tears Severe Gel Drops

Market Overview of Artificial Tears

The global artificial tears market is experiencing significant growth, driven by several key factors. The market size was valued at $2.64 billion in 2019 and is projected to reach $4.30 billion by 2027, with a compound annual growth rate (CAGR) of 5.9%[1].

Key Drivers of the Market

Aging Population and Prolonged Screen Time

The increasing age of the global population and the rise in prolonged screen time are major contributors to the growth of the artificial tears market. These factors lead to a higher incidence of dry eye syndrome, a primary indication for artificial tears[4].

Technological Advancements and Product Innovations

Consistent launches of advanced and innovative products from leading companies are spurring market growth. Products like SYSTANE HYDRATION PF and REFRESH RELIEVA have raised patient awareness and created strong demand for these products[1][5].

Shift from Prescription to OTC

The shift from prescription to over-the-counter (OTC) artificial tears has also boosted market growth. This shift makes the products more accessible to a wider population, contributing to increased sales[4].

Market Segmentation

By Type

The artificial tears market is segmented by type, including glycerin tears, cellulose tears, oil-based emulsion tears, and others. The cellulose-derived segment, which includes products like GenTeal Tears, is a significant contributor to the market[4].

By Dosage

Artificial tears are available in various dosages such as suspensions, solutions, ointments, emulsions, gels, and sprays. GenTeal Tears Severe Gel Drops fall under the gel category, which provides long-lasting relief for dry eye symptoms[4].

By Indication

The primary indication for GenTeal Tears Severe Gel Drops is dry eye syndrome, which is a growing concern due to increasing pollution, global urbanization, and the rise in contact lens usage[4].

GenTeal Tears Severe Gel Drops: Product Overview

Features and Benefits

GenTeal Tears Severe Gel Drops offer fast and long-lasting relief against dry eye symptoms. They provide soothing relief, gentle protection, and safe ingredients that are comfortable and gentle on the eyes. These drops help reduce eye discomfort and irritation quickly and shield the eyes against further irritation[3].

Pricing

The cost for GenTeal Tears Severe Gel Drops is around $17 for a supply of 10 grams, depending on the pharmacy. Generic versions are also available, which can be more cost-effective for consumers[2].

Price Projections and Market Trends

Current Pricing

As of the current market, the price for GenTeal Tears Severe Gel Drops is relatively stable, with prices ranging from $17 to $17.55 for different quantities. The use of discount cards and patient assistance programs can further reduce the cost for consumers[2].

Future Market Growth

The artificial tears market, including products like GenTeal Tears Severe Gel Drops, is expected to grow significantly. The market is projected to reach $4.40 billion by 2031, growing at a CAGR of 5.40% during the forecast period (2023-2031)[5].

Impact of Technological Advancements

Technological advancements, such as the integration of AI and tech, and the development of advanced drug delivery systems, are expected to drive market growth. These innovations will likely lead to more effective and user-friendly products, potentially influencing pricing strategies[4].

Challenges and Limitations

Rising Concerns Associated with Eye Drops

Despite the growth, there are rising concerns associated with eye drops that could limit market growth. These concerns include potential side effects and the need for more stringent regulatory oversight[1].

Regional Market Analysis

Largest and Fastest Growing Markets

The largest market for artificial tears is North America, while the Asia-Pacific region is the fastest growing. This regional growth is driven by increasing urbanization, pollution, and the rising prevalence of dry eye syndrome[5].

Key Takeaways

  • The global artificial tears market is growing significantly, driven by factors such as an aging population, prolonged screen time, and technological advancements.
  • GenTeal Tears Severe Gel Drops are a key product in this market, offering fast and long-lasting relief for dry eye symptoms.
  • The current pricing for GenTeal Tears Severe Gel Drops is around $17 for a 10-gram supply, with potential savings through discount cards and patient assistance programs.
  • The market is expected to continue growing, reaching $4.40 billion by 2031, with a CAGR of 5.40%.

FAQs

  1. What are the primary indications for GenTeal Tears Severe Gel Drops?

    • The primary indication for GenTeal Tears Severe Gel Drops is dry eye syndrome, as well as temporary discomfort or irritation due to dry, tired eyes or outdoor conditions[3].
  2. How much do GenTeal Tears Severe Gel Drops cost?

    • The cost for GenTeal Tears Severe Gel Drops is around $17 for a supply of 10 grams, depending on the pharmacy[2].
  3. Are there any generic versions of GenTeal Tears Severe Gel Drops available?

    • Yes, generic versions of GenTeal Tears Severe Gel Drops are available, which can be more cost-effective for consumers[2].
  4. What are the key drivers of the artificial tears market?

    • Key drivers include the aging population, prolonged screen time, technological advancements, and the shift from prescription to OTC products[4].
  5. What is the projected growth of the artificial tears market by 2031?

    • The artificial tears market is projected to reach $4.40 billion by 2031, growing at a CAGR of 5.40% during the forecast period (2023-2031)[5].

Sources

  1. Fortune Business Insights - Artificial Tears Market Size, Share | Global Industry Report [2020-2027]
  2. Drugs.com - GenTeal Tears Severe Prices, Coupons, Copay Cards & Patient Assistance
  3. MyAlcon - GenTealĀ® Tears Family of Products | Alcon Professional
  4. The Business Research Company - Global Artificial Tears Market Report 2024
  5. Straits Research - Artificial Tears Market Size, Demand, Share, Forecast to 2031

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.